149 related articles for article (PubMed ID: 26722506)
1. Diagnostic significance of miR-106a in gastric cancer.
Hou X; Zhang M; Qiao H
Int J Clin Exp Pathol; 2015; 8(10):13096-101. PubMed ID: 26722506
[TBL] [Abstract][Full Text] [Related]
2. Detection of miR-106a in gastric carcinoma and its clinical significance.
Xiao B; Guo J; Miao Y; Jiang Z; Huan R; Zhang Y; Li D; Zhong J
Clin Chim Acta; 2009 Feb; 400(1-2):97-102. PubMed ID: 18996365
[TBL] [Abstract][Full Text] [Related]
3. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
4. Correlation between microRNA-421 expression level and prognosis of gastric cancer.
Liu H; Gao Y; Song D; Liu T; Feng Y
Int J Clin Exp Pathol; 2015; 8(11):15128-32. PubMed ID: 26823855
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
6. [Expression of plasma miR-106a in colorectal cancer and its clinical significance].
Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448
[TBL] [Abstract][Full Text] [Related]
7. Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.
Zhu M; Zhang N; He S
Pathol Res Pract; 2014 Dec; 210(12):909-15. PubMed ID: 25115709
[TBL] [Abstract][Full Text] [Related]
8. Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer.
Cui L; Zhang X; Ye G; Zheng T; Song H; Deng H; Xiao B; Xia T; Yu X; Le Y; Guo J
Cancer; 2013 May; 119(9):1618-26. PubMed ID: 23335180
[TBL] [Abstract][Full Text] [Related]
9. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
Zhao G; Jiang T; Liu Y; Huai G; Lan C; Li G; Jia G; Wang K; Yang M
BMC Cancer; 2018 Jun; 18(1):676. PubMed ID: 29929476
[TBL] [Abstract][Full Text] [Related]
10. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma.
Tusong H; Maolakuerban N; Guan J; Rexiati M; Wang WG; Azhati B; Nuerrula Y; Wang YJ
Cancer Biomark; 2017; 18(1):79-85. PubMed ID: 27814278
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106a targets TIMP2 to regulate invasion and metastasis of gastric cancer.
Zhu M; Zhang N; He S; Lui Y; Lu G; Zhao L
FEBS Lett; 2014 Feb; 588(4):600-7. PubMed ID: 24440352
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients.
Zheng Y; Cui L; Sun W; Zhou H; Yuan X; Huo M; Chen J; Lou Y; Guo J
Cancer Biomark; 2011-2012; 10(2):71-7. PubMed ID: 22430134
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer.
Qiu X; Zhang J; Shi W; Liu S; Kang M; Chu H; Wu D; Tong N; Gong W; Tao G; Zhao Q; Qiang F; Zhu H; Wu Q; Wang M; Zhang Z
PLoS One; 2016; 11(3):e0151345. PubMed ID: 27010210
[TBL] [Abstract][Full Text] [Related]
16. Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis.
Zhu M; Zhang N; Lu X; He S
Dig Dis Sci; 2018 Oct; 63(10):2604-2616. PubMed ID: 29948558
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer.
Cai H; Yuan Y; Hao YF; Guo TK; Wei X; Zhang YM
Med Oncol; 2013 Mar; 30(1):452. PubMed ID: 23307259
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
